PCM
DERM

Prelude Capital Management’s Dermira, Inc. DERM Stock Holding History

Prelude Capital Management’s Portfolio DERM Stock Details DERM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-800
Closed -$23K – 2021
2017
Q2 		$23K Buy
+800
New +$24.3K ﹤0.01% 1227

Other funds holding DERM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Prelude Capital Management's DERM Position: Q3 2017 in Review

Prelude Capital Management sold out of Dermira, Inc. (DERM) in Q3 2017, closing a stake of 800 shares — an estimated $23K sold.

Prelude Capital Management first reported a position in DERM in Q2 2017 and held it in 1 quarter. The position peaked at $23K in Q2 2017. 123 funds tracked by Wall St. Rank hold DERM as of Q3 2017.

  • Prelude Capital Management reported no remaining Dermira, Inc. position as of Q3 2017 after selling out during the quarter.
  • Prelude Capital Management sold 800 Dermira, Inc. shares in Q3 2017, an estimated $23K.
  • Prelude Capital Management first reported a position in Dermira, Inc. in Q2 2017 and held it in 1 quarter.
  • Prelude Capital Management's Dermira, Inc. position peaked at $23K in Q2 2017.
  • 123 funds tracked by Wall St. Rank held Dermira, Inc. as of Q3 2017.

Based on Prelude Capital Management's 13F filing for Q3 2017, filed 14 Nov 2017.